XKEM update-just tt IR Stephen Burg...the $ 8 million financing is "still in the works and non-dilutive"...they are "ramping up production"...great when "demand is so large"...all good going forward...said " a PR may be out soon" but didn't get any more imfo...all good to me! 9 million people need out drug in Africa alone and we are allowed to sell it there..also, 4 million need it in Nigeria area alone, and that is the first order of business
-------------------- The difference between genius and stupidity is that genius has its limits
IP: Logged |
1. Establish a state-of-the-art cGLP/cGMP facility in Nigeria for the Research, Development and Production of drugs from natural sources using African biodiversity. 2. Bring relief to the millions of Sickle Cell Disease patients through production of NICOSAN™/HEMOXIN™, the drug developed by the Nigerian Scientists at the National Institute for Pharmaceuticals Research and Development (NIPRD), Abuja for the treatment of Sickle Cell Disease.
3. Develop and bring to market an array of existing and new medicines produced and certified to the highest standards to serve the underrepresented needs of both the Nigerian population and that of the whole of Africa.
IP: Logged |
The raw materials and its sources are all said to be within the country, although future international market demand could require growing and obtaining more material from overseas. The drug may be launched as soon as the National Agency for Food and Drug Administration and Control (NAFDAC) approves it. "We are looking into the issue of counterfeiting, but I can't tell you anything specific on that now, admitted Dr. Pandey, explaining, "First, we will make it a prescription drug. So we will know what is going on and how much of it is going out of the company. We may have some pharmaceutical stores to suggest the bulk purchasers. Counterfeiting has been brought to our attent ion by many people, but we are looking into how to stop it from happening to us."
The researchers believe that with the advent of NICOSAN, Sickle Cell Disease may soon be removed from the class of ailments having no specific drugs to cure them anywhere. As Sickle Cell Anaemia takes its toll on the human race, the global public awaits the efficacy of this drug, its standard maintenance, the height of its safety profile, its broad spectrum capacity and its affordability to patients of the disease who, perhaps, may never have hoped for any specific cure in the near future. That is if it proves itself to be the cherished specific cure for the disease.
posted
I can say this now the future of this company looks better than it ever did the only people in the world that have a safe treatment for scd,a factory to produce product, protection granted by the Nigerian Gov. patented product and a huge customer base to follow the product for life or until something better comes along. Plus same type of drugs in the pipeline for aids and other ailments.
Every thing until approval and launch was pure guess and speculation. And this is trading like a pos a lot of the world knows about this and nothing happens you got me. All of Europe does or it would not be on the German exchanges.
IP: Logged |
posted
I hope some time this week we stop this nose dive and turn around this is terrible we might see the low 2's if this keeps up before we turn around
IP: Logged |
posted
This will turn around in time. People will be able to start living normal lives because of the drug and the whole world will start finding out about it.
IP: Logged |
posted
Posted by: dart1961 In reply to: Marilynt who wrote msg# 29583 Date:7/25/2006 9:40:54 AM Post #of 29597
Marilynt- .026-.03 is a good 1st entry for peeps wanting to come aboard now, then kick back and watch for a day or 2, never shoot all your bullets at once IMO!
posted
Posted by: INVestorTrends480 In reply to: None Date:7/25/2006 9:35:12 AM Post #of 29598
MMs = Short Hundreds Of Millions. Pure Manipulation. XKEM will be back up in a few weeks towards new highs. Seen this 100 and 1 times.
Not even in the OTCBB does a stock make roundtrip .03 to .11 and back to .03. At least not companies with actual longterm potential and fundamentals. Clear MM attempt to cover their short cheap.
Expecting a bottom of .026-.028 today. GLTA
My opinions are solely opinions. Do not buy or sell on my opinions.
IP: Logged |
posted
Hi all i just got off the phone with Steve Burg
He did to the best of his ability state the following
(1) contstruction for the main factory ansd he did refer to that as a factory has been going on now for about 2weeks. look for it to be s built equiped and running at 100% in 6 to 9 months
(2)Small plant is running at 100% capacity now and the are wharehousing as much as possible they are running a small trial program. When distrubution gets handled they will be able to get the product out with no shortages
(3) He can not dicuss production now but he is in the processof getting capcity figures for us and estimates should hear some of that in a month or so.
(4) And now the 8 million dollar loan that will finish the factory and speed them to the finish. As per Steve the final paper work is in the works they have a verbal approrval but nothing is final until check is in hand but it appears that all systemes are go. Not to worry if anything happens they have lots of offers now to look at if by some remote reason this does not work. But he is sure it will be done and sooner than I may think and he says he can't wait to get the news out. Over and Over he stated we are real how many company's do you know that the president of the country comes to your grand opening. thats all we talked about glta
IP: Logged |
posted
I believe that the smaller factory is only 20000sq ft there office and lab in New Jersey is 35,000 sq ft I don't know about the office in China and they are producing product
IP: Logged |
quote:Originally posted by bond006: Posted by: INVestorTrends480 In reply to: None Date:7/25/2006 9:35:12 AM Post #of 29598
MMs = Short Hundreds Of Millions. Pure Manipulation. XKEM will be back up in a few weeks towards new highs. Seen this 100 and 1 times.
Not even in the OTCBB does a stock make roundtrip .03 to .11 and back to .03. At least not companies with actual longterm potential and fundamentals. Clear MM attempt to cover their short cheap.
Expecting a bottom of .026-.028 today. GLTA
My opinions are solely opinions. Do not buy or sell on my opinions.
this makes a lot of sense, they had to be short after that run. looks to me like the wanted to cover by tomorrow. they took this down hard from .10
posted
from what I have heard and it was months ago that the original 20000. sq ft factory could handle Nigeria but the company would like to be in 1 year to be able to distribute product to all of africa and the rest of the world
IP: Logged |
No No No. Thats the Naked Short ammount. MMs are short a couple Hundred Million Shares (300-500mln imho) in order to maintain a market on XKEM during the 4 Billion Volume run from .03 to .11. That 1.13million short interest is Naked short which shows up on the SHO list and is made public by the Nasdaq. MMs are short a hell lot more than 1.13 Million shares of which you wont know because it is their inventory short that the Nasdaq cant disclose.
If that doesnt make common sense, ill simplify it.
Market Makers HAVE to short shares on a stock that has demand like XKEM did trading 4 Billion+.
They exceeded their inventory during the 4Billion share month so they had to short heavily to cover the demand. 1.13Naked Short big difference from MMs inventory shorts.
Bashers are actually using that 1.13 Naked short number to say "they're only short 1.13 Million." Because its obvious they work for these guys...its their only way out.
XKEM a great fundamental company is trading back where it started at .03 down from .11. Besides obvious profit taking, but to a greater extent MMs needing to cover their short and inducing a walkdown and selloffs. MMs are short BIG and they will have to Cover. It all depends at what price XKEM investors let them cover at. GLTA.
XKEM will be up nice from these levels over the next few months, sell if you have to.
IP: Logged |
posted
I'm holding still with a buy in at .05. sucks to see such good stock go down but this one has lots of reason to go up. I have an investment covering sell of a portion of my shares at .10 ... it will be filled I believe... then the rest will ride higher. A unique niche in SCD treatment... great potential!
-------------------- learnin as I go.
IP: Logged |
posted
XKEM New Article!! President Obasanjo urges Nigerians to support NICOSAN....
Diaspora: We Must Take Our Future in Our Hands –Obasanjo Orders govt agencies to be online by Dec. From Patrick Ugeh in Abuja, 07.26.2006
As part of his vision to make Nigeria one of the 20 largest economies in the world by 2020, President Olusegun Obasanjo has charged Nigerians in the Diaspora and at home to take the country's destiny in their hands, even as he announced the Federal Government's resolve to grow the economy by 10% annually. The president, who spoke while declaring open the second Diaspora Day in Abuja yesterday, traced the genesis of one of the greatest problems complained about by Nigerians in the Diaspora to the fact that for ten years there was no investment in the energy sector. He said the government plans to correct the situation and others through NEEDS which he stated aims at attaining the Millennium Development Goals through which the governments sets and achieves its targets. "We want to grow the economy by a minimum of 10 per cent every year from this year," he said. "This means that every six to seven years we will be doubling our economic growth. It is possible and we will do it. By 2020, we want the Nigerian economy to be among the twenty largest in the world. It is possible and we will do it. But we must do it together. All Niigerians must apply themselves to bridge the gap between the status of developed and underdeveloped." According to him, this was necessary because there's not quick fix or short cut to the issue of development, pointing out that Nigeria was yet to realise its full potential and as still requires assistance of those in the Diaspora for growth and to manage its affairs. He directed that by December, all ministries an government establishments must have "robust and dynamic" websites so that all those wishing to access any information would have no cause to travel physically to the source. "Henceforth, there should be no excuse for Nigerians to travel home to seek information when they can get it through the internet," he said. He added that such active websites would also help douse rumours and misinformation which foreigners have of this country as they would be able access any information they desire without constraints. He allayed one of the fears of citizens living abroad, accommodation, by announcing that the Federal Secretariat in Ikoyi, Lagos State, was being remodelled by the government to quarter those willing to come back home. Commending them for their contributions to nation-building so far, he urged them to take advantage of the efforts of the government to create an enabling environment and collaborate with professionals at home to help uplift the nation. In particular, Obasanjo he called on Nigerianscientists abroad to support the National Science
Foundation by helping to generate funds for it and promised that government would give them all the necessary support in all their endeavours to improve the quality of life in Nigeria. He urged the Nigerians in Diaspora to pool their resources to further the accomplishments of the government in the last few years in such areas as science and technology, computer availability as epitomised by the CANI (Computer for All Nigerians Initiative) and the manufacture of the Nicosan drug. He also noted that while all Nigerians whether in foreign lands or at home wer working collectively for the upliftment of the country, those in the Diaspora should emulate their counterparts from other countries like Israel and India by using their leverage to attract foreign assistance to Nigeria. The president conceded that the country does need the external help to help it get to the desideratum and that the Nigerian Diaspora were well placed to achieve the goal.
Urging them not to allow their passion for this country to diminish but to pass it on their offspring, he told them to be good world citizens so that they could equally remain good citizens when they return to Nigeria. He said while there were a few bad eggs among them, the majority of Nigerians abroad were virtuous and advised them to go the extra length of helping to expose the criminally minded ones with a view to getting them repatriated.Expressing delight at the effort of the Nigerian National Volunteer Service (NNVS) which, in conjunction with the Ministry of Science and Technology, organised the event, he appealed to his "bosses" at the Matinal Assembly to pass the NNVS bill that has been pending before them in the last two years.When passed, the law will aid the work and aspirations of the Nigerian Diaspora, he said. Minister of Science and Technology, Prof. Turner Isoun, declared that the goal of the government is to make computers as ubiquitous as GSM phones. He told participants that the Nigerian Energy Commission designed to promote nuclear capability for the production of electricity, among others, is billed for commissioning on Monday.
Expressing his desire to see the National Diaspora Day, at which Nigerians in the Diaspora come to brainstorm on ways to improve Nigeria, sustained, Isoun hoped that Nigerians would seize the initiatives of this administration to participate in national development. The chairman of Nigerians in the Diaspora in the Americas, Dr. Ola Kazeem, who declared that the Nigerian Diaspora were economic refugees, said they were in the process of reversing the brain drain experienced by Nigeria in recent years. According to him, efforts were on to encourage Nigerian nurses who migrated to return home, even as he stated their determination to be champion the cause of the country wherever they may be.
"We are economic refugees," he said. "The only thing stopping many of us from coming back home is that there is no accommodation... we will help to develop Nigeria. We will be champions for the country, just like the Jewish Defence League is to Israel."
posted
I holding and buying more Stocks like this don't come around every day Next year we will be talking about xkem. I am not missing out on this one,
Go XKEM
------------------------- Risk is in the eye of the beholder.
IP: Logged |
posted
Demand for New Sickle Cell Drug NICOSAN(TM) Far Exceeds Supply; Xechem Nigeria Accelerates Construction of Commercial Scale Production Facility
-------------------------------------------------------------------------------- Wed Jul 26 06:44:38 2006 EDT NEW BRUNSWICK, N.J., Jul 26, 2006 (BUSINESS WIRE) -- Xechem International, Inc. (OTC BB: XKEM) announced today that response to the first limited sales and distribution of NICOSAN(TM), its new product for the prophylactic management of Sickle Cell Disease (SCD), by its subsidiary, Xechem Pharmaceuticals Nigeria, Ltd. (Xechem Nigeria), has been far greater than anticipated. Xechem Nigeria has broken ground for a new state-of-the-art commercial scale production facility and accelerated the facility's construction schedule. Xechem Nigeria, which received regulatory approval for NICOSAN(TM), its first major breakthrough "Natural Herbal Drug," on July 3rd, 2006 from the National Agency for Food and Drug Administration and Control of Nigeria (NAFDAC), has been producing the drug in limited quantities at its pilot scale facility in Abuja, Nigeria.
Xechem Nigeria's new commercial scale facility will have capacity to meet the demand of Nigeria and other African countries. Nigeria alone has 4 million sickle cell disease patients. The new facility will also be able to supply the drug for the clinical trials in the United States and the European Union.
NICOSAN(TM) was launched by the President of Nigeria, His Excellency Chief Olusegun Obasanjo on July 6th, 2006 at SHESTCO Complex. Immediately after the launch ceremony Xechem Nigeria has started direct sales of NICOSAN(TM) in Abuja, the Federal Capital Territory of Nigeria.
The drug is taken through one-a-day capsules which, once started, must be taken daily by the patient. The current price for a months supply for Adults is established at N 3,000 Naira (approx. US $23) and for Pediatrics at N 2,400 Naira (approx. US $18), respectively. Xechem is also accepting mail orders for the drug from other States within Nigeria.
The financing for this first phase of construction was supplied by Nigerian Export-Import (NEXIM) Bank, which loaned Xechem Nigeria N150 Million Naira (US$1.2 million) in June of this year. Xechem estimates that the expanded facility will be fully operational within 9 months.
Dr. Ramesh Pandey, Chairman and CEO of the Xechem Companies said, "This is a very exciting time for Xechem and one that has been more than four years in the making. Getting NICOSAN(TM) approved for the prophylactic management of Sickle Cell Disease (SCD) was a major milestone which changes Xechem from a research and development company to a full scale business venture with NICOSAN(TM) to market.
"This also required the construction of a full scale production facility, on which we have now broken ground This plant will meet all the current Good Manufacturing Practices (cGMP) guidelines, the first facility in Nigeria to do so. We are grateful to NEXIM Bank for the loan and their early support for this project. This will help ensure the completion of our expanded facility in the shortest possible timeframe. Xechem is very proud to be the leader in bringing NICOSAN(TM) for Sickle Cell sufferers first in Nigerian market which will be followed throughout the African continent and the world."
About NICOSAN(TM)
NICOSAN(TM) is an anti-sickling, phyto-pharmaceutical (Natural Herbal Drug) for the prophylactic management of Sickle Cell Disease (SCD). It was developed by Nigerian scientists at the National Institute for Pharmaceutical Research and Development (NIPRD). In clinical studies conducted under NIPRD's auspices, the drug has shown to substantially reduce the degree of sickling of the red blood cells of those afflicted with the disease. While not a cure, the clinical trials have confirmed that the large majority of patients taking NICOSAN(TM) no longer experience sickle cell "crises" while on the medication, and even among those whose crises are not eliminated, the number and severity of the crises are substantially reduced. Preliminary studies carried out at the National Heart, Lung and Blood Institute Sickle Cell Disease Reference Laboratory (NHLBI-SCDRL), NIH, at the Children's Hospital of Philadelphia (CHOP) and Xechem Research Laboratory in New Brunswick, NJ have confirmed some of the Nigerian studies.
About Sickle Cell Disease
Sickle Cell Disease (SCD) is an inherited blood disorder caused by an abnormality in the hemoglobin molecule. Patients with the disease often produce stiff, abnormally shaped red blood cells that often do not flow freely through the blood vessels. This can create clogs in the vessels, which in turn cut off the flow of normal hemoglobin and oxygen to parts of the body, and can cause severe painful attacks or "crises", damage to various organs and shortened life spans. People with SCD often suffer unpredictable painful crises several times a year lasting from a few hours to a week or more. In the US, there are approximately 80,000 patients with SCD. In Nigeria, that number is believed to be approximately 4 million, and worldwide at least 12 million individuals are afflicted with SCD.
About Xechem
Xechem International is a development stage biopharmaceutical company working on anticancer, antiviral (including AIDS), antifungal, antimalarial and antibacterial products from natural sources, including microbial and marine organisms. Its focus is on the development of phyto-pharmaceuticals (natural herbal drugs) and other proprietary technologies, including those used in the treatment of orphan diseases. Xechem's mission is to bring relief to the millions of people who suffer from these diseases. Its recent focus and resources have been directed primarily toward the development and launch of NICOSAN(TM) (to be marketed as HEMOXIN(TM) in the US and Europe). With the Nigerian regulatory approval now in hand, Xechem has turned to the commercialization of the drug in Nigeria and plans also to pursue US FDA and European regulatory approval. In addition to NICOSAN(TM), Xechem is also working on another sickle cell compound, 5-HMF, which it has licensed from Virginia Commonwealth University.
Forward Looking Statements
This press release contains certain forward looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended, which are intended to be covered by safe harbors created hereby. Such forward-looking statements involve known and unknown risks and uncertainties.
SOURCE: Xechem International, Inc.
CONTACT: Xechem International, Inc. Stephen Burg, 707-425-8855
Copyright Business Wire 2006
-0-
KEYWORD: United States Nigeria North America Africa/Middle East New Jersey INDUSTRY KEYWORD: Health Alternative Medicine Biotechnology Genetics Pharmaceutical Other Health SUBJECT CODE: Product/Service
posted
Great PR...It shows the enormous sales this drug is generating...this should wake this puppy up this morning...
Nice to get low interest loans to manufacture a product where the demand is huge...By the time this is fully operational in nine months the products will have a line of orders waiting...Now that's nice...Time to get in this morning...
IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
